Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery.

Michael SheuMolina Garcia SofiaWei WeiGrady PatrickApostolakis JohnAngelini Dana

Published in: Perfusion (2023)

There was no difference in the composite outcome of thrombotic or hemorrhagic complications in patients monitored by Hepcon versus those monitored by ACT.

Keyphrases

cardiac surgery
patients undergoing
end stage renal disease
newly diagnosed
chronic kidney disease
risk factors
acute kidney injury
peritoneal dialysis
prognostic factors